{"url":"https://lda.senate.gov/api/v1/filings/62e99289-2dc8-4e4e-bb1f-0a115d5ad705/","filing_uuid":"62e99289-2dc8-4e4e-bb1f-0a115d5ad705","filing_type":"RA","filing_type_display":"Registration - Amendment","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/62e99289-2dc8-4e4e-bb1f-0a115d5ad705/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"James \"J.D.\" Derderian","dt_posted":"2022-12-09T15:23:40-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"182 Prince George Street","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Annapolis","registrant_state":"MD","registrant_zip":"21401","registrant":{"id":83717,"url":"https://lda.senate.gov/api/v1/registrants/83717/","house_registrant_id":36456,"name":"STANTON PARK GROUP","description":"government affairs","address_1":"182 Prince George Street","address_2":null,"address_3":null,"address_4":null,"city":"Annapolis","state":"MD","state_display":"Maryland","zip":"21401","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES DERDERIAN","contact_telephone":"+1 202-549-1472","dt_updated":"2026-07-28T16:47:17.343412-04:00"},"client":{"id":172125,"url":"https://lda.senate.gov/api/v1/clients/172125/","client_id":1000824,"name":"BRAEBURN PHARMACEUTICALS, INC.","general_description":"pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-09-25"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"HR 5950 and S 3257, the Improving Patient Access to Care and Treatment Act. Reducing stigma and promoting treatment of opioid use disorder; raising awareness of the benefits of medication assisted therapy (MAT); ensuring patient access to MAT; FDA approval and exclusivity process; patient access to practitioner-administered therapies","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":53472,"prefix":null,"prefix_display":null,"first_name":"VALERIE","nickname":null,"middle_name":null,"last_name":"HENRY","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo","new":true},{"lobbyist":{"id":67522,"prefix":null,"prefix_display":null,"first_name":"JOSEPH","nickname":null,"middle_name":null,"last_name":"RACHINSKY","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":true},{"lobbyist":{"id":139835,"prefix":"mr","prefix_display":"MR.","first_name":"BRYAN","nickname":null,"middle_name":"WILLIAM","last_name":"WELLS","suffix":null,"suffix_display":null},"covered_position":"Policy Advisor, Senator Pat Roberts","new":true},{"lobbyist":{"id":54701,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"DERDERIAN","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}